| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
10,950,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile MAIA Biotechnology is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. Co.'s primary product candidate, 6-thio-dG or 6-thio-2'-deoxyguanosine (THIO), is a telomere-targeting agent in clinical development to evaluate its activity in non-small cell lung cancer (NSCLC). THIO is being developed as a second- or later line of treatment for NSCLC for patients that have progressed beyond the standard-of-care regimen of existing checkpoint inhibitors. Co.'s pipeline includes THIO-102, which is targeting colorectal cancer and THIO-103, which is targeting basket study.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
56,030 |
89,363 |
436,113 |
1,288,801 |
| Total Buy Value |
$61,146 |
$111,146 |
$660,443 |
$2,113,796 |
| Total People Bought |
2 |
2 |
3 |
6 |
| Total Buy Transactions |
5 |
6 |
14 |
25 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2025-08-30 |
2025-05-29 |
2024-11-28 |
2023-11-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Smith Stan |
Director |
• • – |
2025-11-25 |
4 |
B |
$0.98 |
$14,700 |
I/I |
15,000 |
1,349,289 |
2.1 |
- |
|
| Smith Stan |
Director |
• • – |
2025-11-24 |
4 |
B |
$0.99 |
$9,900 |
I/I |
10,000 |
1,334,289 |
2.1 |
- |
|
| Vitoc Vlad |
Chief Executive Officer |
• • • |
2025-11-24 |
4 |
B |
$0.99 |
$9,891 |
D/D |
10,000 |
820,921 |
3.15 |
- |
|
| Vitoc Vlad |
Chief Executive Officer |
• • • |
2025-11-21 |
4 |
B |
$0.92 |
$1,656 |
D/D |
1,800 |
810,921 |
3.15 |
- |
|
| Smith Stan |
Director |
• • – |
2025-10-01 |
4 |
B |
$1.30 |
$24,999 |
I/I |
19,230 |
1,324,289 |
2.1 |
- |
|
| Smith Stan |
Director |
• • – |
2025-06-03 |
4 |
B |
$1.50 |
$50,000 |
I/I |
33,333 |
1,305,059 |
2.1 |
- |
|
| Smith Stan |
Director |
• • – |
2025-05-08 |
4 |
B |
$1.50 |
$99,999 |
I/I |
66,666 |
1,271,726 |
2.1 |
- |
|
| Guerrero Ramiro |
Director |
• • – |
2025-05-08 |
4 |
B |
$1.50 |
$30,000 |
D/D |
20,000 |
588,218 |
2.39 |
- |
|
| Guerrero Ramiro |
Director |
• • – |
2025-03-03 |
4 |
B |
$1.50 |
$50,000 |
D/D |
33,333 |
568,218 |
2.39 |
- |
|
| Smith Stan |
Director |
• • – |
2025-03-03 |
4 |
B |
$1.50 |
$37,500 |
I/I |
25,000 |
1,205,060 |
2.1 |
- |
|
| Guerrero Ramiro |
Director |
• • – |
2025-02-24 |
4 |
B |
$1.50 |
$110,000 |
D/D |
73,333 |
534,885 |
2.39 |
- |
|
| Smith Stan |
Director |
• • – |
2025-02-24 |
4 |
B |
$1.50 |
$75,000 |
I/I |
50,000 |
1,180,060 |
2.1 |
- |
|
| Guerrero Ramiro |
Director |
• • – |
2024-12-13 |
4 |
B |
$1.87 |
$99,998 |
D/D |
53,418 |
514,970 |
2.39 |
- |
|
| Smith Stan |
Director |
• • – |
2024-12-13 |
4 |
B |
$1.87 |
$46,800 |
I/I |
25,000 |
1,130,060 |
2.1 |
- |
|
| Smith Stan |
Director |
• • – |
2024-11-01 |
4 |
B |
$2.51 |
$251,000 |
I/I |
100,000 |
957,568 |
2.1 |
- |
|
| Guerrero Ramiro |
Director |
• • – |
2024-11-01 |
4 |
B |
$2.51 |
$222,220 |
D/D |
88,534 |
408,134 |
2.39 |
- |
|
| Luput Cristian |
Director |
• • – |
2024-11-01 |
4 |
B |
$2.51 |
$55,554 |
D/D |
22,133 |
389,483 |
2.39 |
- |
|
| Chaouki Steven M |
Director |
• • – |
2024-11-01 |
4 |
B |
$2.51 |
$55,554 |
D/D |
22,133 |
111,024 |
2.39 |
- |
|
| Smith Stan |
Director |
• • – |
2024-04-25 |
4 |
B |
$2.03 |
$299,409 |
I/I |
147,492 |
1,005,060 |
2.1 |
- |
|
| Louie Ngar Yee |
Director |
• • – |
2024-04-25 |
4 |
B |
$2.03 |
$39,920 |
D/D |
19,665 |
1,167,189 |
2.39 |
- |
|
| Chaouki Steven M |
Director |
• • – |
2024-03-14 |
4 |
B |
$1.17 |
$40,530 |
D/D |
34,641 |
88,891 |
2.39 |
- |
|
| Luput Cristian |
Director |
• • – |
2024-03-14 |
4 |
B |
$1.17 |
$81,060 |
D/D |
69,282 |
367,350 |
2.39 |
- |
|
| Smith Stan |
Director |
• • – |
2024-03-14 |
4 |
B |
$1.17 |
$200,000 |
I/I |
170,940 |
857,568 |
2.1 |
- |
|
| Louie Ngar Yee |
Director |
• • – |
2024-03-14 |
4 |
B |
$1.17 |
$200,000 |
D/D |
170,940 |
1,147,524 |
2.39 |
- |
|
| Guerrero Ramiro |
Director |
• • – |
2024-03-14 |
4 |
B |
$1.17 |
$8,106 |
D/D |
6,928 |
319,600 |
2.39 |
- |
|
129 Records found
|
|
Page 1 of 6 |
|
|
